A Study Of SHIFT: Search For Health Indicators At Felicitous Time

Overview

About this study

The purpose of this study is to test the feasibility of tracking longitudinal molecular trajectories in self-collected menstrual blood from perimenopausal individuals with ongoing menstrual bleeding.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • You are at least 45 years or older and peri-menopausal

  • You currently have menstrual cycles or menstrual bleeding episodes.

Exclusion Criteria:

  • You are younger than 45 years of age.

  • You are pregnant or nursing.

  • You are postmenopausal (12 months without menstrual bleeding).

  • You have a cancer diagnosis

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 04/13/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Marina Walther-Antonio, Ph.D.

Open for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions